SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-21-025617
Filing Date
2021-07-26
Accepted
2021-07-26 16:12:41
Documents
2
Group Members
GENTING BERHADLIM KOK THAY

Document Format Files

Seq Description Document Type Size
1 SC 13D brhc10027240_sc13d.htm SC 13D 135975
2 EXHIBIT 99.1 brhc10027240_ex99-1.htm EX-99.1 8123
  Complete submission text file 0001140361-21-025617.txt   145815
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Subject) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91021 | Film No.: 211114258
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 24TH FLOOR, WISMA GENTING JALAN SULTAN ISMAIL KUALA LUMPUR N8 50250
Business Address C/O 24TH FLOOR, WISMA GENTING JALAN SULTAN ISMAIL KUALA LUMPUR N8 50250 603 2333 6888
Dragasac Ltd (Filed by) CIK: 0001872884 (see all company filings)

IRS No.: 981594646 | State of Incorp.: Y8 | Fiscal Year End: 1231
Type: SC 13D